Skip to main content
ARQT logo
ARQT
(NASDAQ)
Arcutis Biotherapeutics, Inc.
$23.63-- (--)
Loading... - Market loading

Arcutis Biotherapeutics (ARQT) Stock Price & Financial Analysis

Arcutis Biotherapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$23.20 - $24.08
52-Week High$31.77
52-Week Low$11.86
Open$23.40
Volume666.40K
Average Volume (3M)666.40K
Market Cap3.01B
Shares Outstanding127.23M
Price to Sales (P/S)8.15
Price to Book (P/B)16.18
EV/EBITDA1221.65
Revenue (TTM)376.07M
Net Income (TTM)-16.14M
Free Cash Flow (TTM)-16.31M
EPS (TTM)$-0.12
Profit Margin-4.29%
Operating Margin-3.25%
Return on Equity (ROE)-8.52%
Debt to Equity0.03
50-Day MA$24.94
200-Day MA$21.84
52-Week Change60.88%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Arcutis Biotherapeutics

What is the current stock price for ARQT?

As of the latest trading session, ARQT stock trades at $23.63. The 52-week range is $11.86–$31.77, with a day range of $23.20–$24.08.

What is the P/E ratio for ARQT?

The P/E ratio (Price-to-Earnings) for ARQT is shown in the Key Statistics section. This valuation metric helps compare Arcutis Biotherapeutics, Inc. to industry peers.

Does ARQT pay dividends?

Arcutis Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ARQT?

Based on 7 analysts, the consensus for ARQT is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ARQT?

Arcutis Biotherapeutics's market capitalization is $3.01B, classifying it as a mid-cap company. Arcutis Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.